Recent

% | $
Quotes you view appear here for quick access.

OCATA THERAPEUTICS, INC. Message Board

  • lastbullstanding lastbullstanding Feb 15, 2013 10:51 AM Flag

    ISCO ain't squat for revenue

    didn't want meet and potatoes lost in shuffle

    "Pursuant to the Amendment all minimum R&D requirements and all milestone payments due to ACT under the Exclusive License Agreement have been eliminated. The Company will no longer pay any royalties under the ACT IP Agreement and Infigen IP Agreement, and its obligation to pay royalties that ranged from 6%-12% under the UMass IP Agreement has been reduced to 0.25% of the net sales of products using technology covered by the UMass IP Agreement. "

    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
ACTC
0.00(0.00%)